Boston Beer
SAM NYSE Distillers & Vintners Financials FY2016βFY2025
Boston Beer's revenue fell 2.4% to $2.0 billion in fiscal 2025. Its operating margin was 7.4%, up from 3.8% a year earlier. Free cash flow was $216 million, up 24.9%. It paid out $202 million in dividends and buybacks, 94% of free cash flow. The diluted share count fell 7.0%.
About these figures. Boston Beer reports no borrowings (its credit line is undrawn), so debt is counted as zero.
What Boston Beer does
No business description yet.
- Legal name
- THE BOSTON BEER COMPANY, INC.
- Fiscal year ends
- December 27, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-067467
0000949870
Revenue and margins
Boston Beer had $2.0B of revenue in fiscal 2025, down 2.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 4.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $216M in fiscal 2025, 11.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Boston Beer returned $202M to shareholders in fiscal 2025, 94% of free cash flow. The diluted share count fell 7.1%.
Value Boston Beer yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $222M and divides by 10.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Boston Beer can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $26.9M | $181M | $299M | $212M | $223M |
| Debt incl. finance leases | $3.1M | $1.5M | $2.7M | $2.8M | $1.1M |
| Net debt / EBITDA | β0.3x | β1.0x | β1.6x | β1.2x | β0.9x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.4x | 2.1x | 2.3x | 1.8x | 1.7x |
| Quick ratio | 0.8x | 1.4x | 1.7x | 1.3x | 1.3x |
| Total assets | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B |
| Total liabilities | $403M | $352M | $352M | $334M | $347M |
| Shareholders' equity | $983M | $1.1B | $1.1B | $916M | $846M |
| Net debt (β = net cash) | β$23.8M | β$179M | β$296M | β$209M | β$222M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.6M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2025 | Michael SpillaneDirector | Sold | 3,120 | $205.78 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 5 / 9 | 7 / 9 |
| Accruals ratio | β13.3% | β14.1% | β13.2% |
| Altman Z'' | 5.93 | 4.89 | 4.68 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Boston Beer SAM | $2.1B | β2.4% | 7.4% | 11.0% | 15.4% | β | 7 | |
| BrownβForman BF-B | $13.5B | β1.2% | 25.5% | 22.7% | 12.9% | 19.0x | 6 | Compare β |
| Constellation Brands STZ | β | β10.5% | 29.8% | 19.6% | 10.7% | β | β | Compare β |
| Molson Coors TAP | $8.2B | β4.2% | β21.0% | 9.6% | β10.7% | β | 3 | Compare β |
| Anheuser-Busch InBev BUD | β | β0.8% | 26.0% | 18.9% | β | β | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $906M | $863M | $996M | $1.2B | $1.7B | $2.1B | $2.1B | $2.0B | $2.0B | $2.0B |
| Gross profit | $460M | $450M | $512M | $614M | $815M | $798M | $862M | $852M | $894M | $953M |
| Operating income | $138M | $116M | $116M | $145M | $244M | $8.0M | $90.8M | $100M | $76.0M | $145M |
| Interest expense | β | β | β | $0.5M | $0.2M | β | β | β | β | β |
| Pretax income | $137M | $116M | $116M | $144M | $244M | $6.9M | $91.4M | $110M | $87.6M | $154M |
| Income tax | $49.8M | $17.1M | $23.6M | $34.3M | $52.3M | β$7.6M | $24.2M | $33.3M | $27.9M | $45.0M |
| Net income | $87.3M | $99.0M | $92.7M | $110M | $192M | $14.6M | $67.3M | $76.2M | $59.7M | $109M |
| Diluted EPS | $6.79 | $8.09 | $7.82 | $9.16 | $15.53 | $1.17 | $5.44 | $6.21 | $5.06 | $9.89 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $154M | $136M | $163M | $178M | $253M | $56.3M | $200M | $265M | $249M | $270M |
| Capital expenditure | $49.9M | $33.0M | $55.5M | $93.2M | $140M | $148M | $90.6M | $64.1M | $76.3M | $54.6M |
| Free cash flow | $104M | $103M | $108M | $85.0M | $113M | β$91.6M | $109M | $201M | $173M | $216M |
| Depreciation and amortization | $49.6M | $51.3M | $52.0M | $56.3M | $65.7M | $72.1M | $81.4M | $88.1M | $94.0M | $90.4M |
| Stock-based compensation | $6.1M | $6.3M | $10.0M | $12.3M | $15.3M | $18.6M | $14.0M | $17.0M | $19.0M | $21.8M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $165M | $145M | $88.3M | $0.0M | $0.0M | $0.0M | $0.0M | $92.9M | $239M | $202M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $165M | $145M | $88.3M | $0.0M | $0.0M | $0.0M | $0.0M | $92.9M | $239M | $202M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $91.0M | $65.6M | $108M | $36.7M | $163M | $26.9M | $181M | $299M | $212M | $223M |
| Total debt | $0.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $2.6M | $4.1M | $3.1M | $1.5M | $2.7M | $2.8M | $1.1M |
| Current assets | $194M | $168M | $232M | $219M | $413M | $345M | $423M | $504M | $417M | $418M |
| Current liabilities | $102M | $102M | $121M | $181M | $259M | $255M | $204M | $223M | $232M | $253M |
| Inventory | $52.5M | $50.7M | $70.2M | $106M | $131M | $149M | $148M | $116M | $117M | $92.5M |
| Property and equipment, net | $408M | $384M | $390M | $541M | $623M | $665M | $668M | $643M | $616M | $578M |
| Total assets | $616M | $570M | $640M | $1.1B | $1.4B | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B |
| Total liabilities | $169M | $146M | $180M | $318M | $422M | $403M | $352M | $352M | $334M | $347M |
| Shareholders' equity | $447M | $424M | $460M | $736M | $957M | $983M | $1.1B | $1.1B | $916M | $846M |
| Margins | ||||||||||
| Gross margin | 50.7% | 52.1% | 51.5% | 49.1% | 46.9% | 38.8% | 41.2% | 42.4% | 44.4% | 48.5% |
| Operating margin | 15.2% | 13.4% | 11.6% | 11.6% | 14.1% | 0.4% | 4.3% | 5.0% | 3.8% | 7.4% |
| EBITDA margin | 20.7% | 19.3% | 16.9% | 16.1% | 17.8% | 3.9% | 8.2% | 9.4% | 8.4% | 12.0% |
| Net margin | 9.6% | 11.5% | 9.3% | 8.8% | 11.1% | 0.7% | 3.2% | 3.8% | 3.0% | 5.5% |
| FCF margin | 11.5% | 11.9% | 10.9% | 6.8% | 6.5% | β4.5% | 5.2% | 10.0% | 8.6% | 11.0% |
| Returns | ||||||||||
| Return on capital | 24.2% | 27.6% | 26.0% | 21.0% | 25.6% | 0.9% | 7.2% | 8.3% | 7.0% | 15.4% |
| Return on capital employed | 26.3% | 23.6% | 23.5% | 20.8% | 24.5% | 0.7% | 7.7% | 8.3% | 6.8% | 14.8% |
| Return on equity | 19.2% | 22.8% | 21.0% | 18.4% | 22.7% | 1.5% | 6.6% | 7.1% | 6.0% | 12.3% |
| Return on assets | 13.9% | 16.7% | 15.3% | 13.0% | 15.8% | 1.1% | 4.8% | 5.4% | 4.5% | 8.9% |
| Growth | ||||||||||
| Revenue growth | β5.6% | β4.8% | 15.4% | 25.5% | 38.9% | 18.5% | 1.6% | β3.9% | 0.2% | β2.4% |
| Net income growth | β11.2% | 13.4% | β6.5% | 18.8% | 74.4% | β92.4% | 362.2% | 13.4% | β21.7% | 81.7% |
| EPS growth | β6.3% | 19.2% | β3.3% | 17.1% | 69.5% | β92.5% | 365.0% | 14.2% | β18.5% | 95.5% |
| FCF growth | 10.4% | β1.2% | 4.9% | β21.3% | 33.4% | β180.8% | β | 83.9% | β14.2% | 24.9% |
| Share count change | β5.4% | β4.8% | β3.7% | 1.5% | 3.2% | 1.3% | β0.7% | β0.7% | β4.0% | β7.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.5x | β0.4x | β0.7x | β0.2x | β0.5x | β0.3x | β1.0x | β1.6x | β1.2x | β0.9x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β | β | β | 321.3x | 992.7x | β | β | β | β | β |
| Current ratio | 1.9x | 1.7x | 1.9x | 1.2x | 1.6x | 1.4x | 2.1x | 2.3x | 1.8x | 1.7x |
| Quick ratio | 1.4x | 1.2x | 1.3x | 0.6x | 1.1x | 0.8x | 1.4x | 1.7x | 1.3x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.5% | 3.8% | 5.6% | 7.5% | 8.1% | 7.2% | 4.3% | 3.2% | 3.8% | 2.8% |
| Stock comp / revenue | 0.7% | 0.7% | 1.0% | 1.0% | 0.9% | 0.9% | 0.7% | 0.8% | 0.9% | 1.1% |
| Payouts / FCF | 157.9% | 140.4% | 81.8% | 0.0% | 0.0% | β | 0.0% | 46.2% | 138.2% | 93.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 7.0 | 7.0 | 5.0 | 5.0 | 3.0 | 8.0 | 7.0 | 5.0 | 7.0 |
| Altman Z'' | 5.8 | 5.5 | 5.3 | 4.1 | 5.2 | 3.9 | 5.6 | 5.9 | 4.9 | 4.7 |
| Accruals ratio | β10.6% | β6.2% | β11.7% | β8.1% | β5.1% | β3.0% | β9.5% | β13.3% | β14.1% | β13.2% |
Source: SEC EDGAR XBRL filings (CIK 0000949870). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.